Compare FIVN & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FIVN | BHVN |
|---|---|---|
| Founded | 2001 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 2014 | 2022 |
| Metric | FIVN | BHVN |
|---|---|---|
| Price | $27.45 | $13.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 14 |
| Target Price | $26.06 | ★ $29.08 |
| AVG Volume (30 Days) | ★ 2.4M | 2.1M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 364.71 | 26.08 |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $1,149,088,000.00 | N/A |
| Revenue This Year | $11.39 | N/A |
| Revenue Next Year | $10.00 | N/A |
| P/E Ratio | $132.40 | ★ N/A |
| Revenue Growth | ★ 10.28 | N/A |
| 52 Week Low | $13.29 | $7.48 |
| 52 Week High | $28.86 | $18.57 |
| Indicator | FIVN | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 63.52 | 43.50 |
| Support Level | $17.66 | $9.42 |
| Resistance Level | N/A | $14.01 |
| Average True Range (ATR) | 1.67 | 0.83 |
| MACD | 0.23 | -0.33 |
| Stochastic Oscillator | 81.91 | 10.90 |
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Intelligent CX platform combines core telephony functionality, omnichannel engagement, and modules into a cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, and optimization solutions, as well as artificial intelligence-driven automation solutions that optimize customer service efficiency and manage interaction quality and agent performance.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.